Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mauricio Moreno

Concepts (265)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Free Tissue Flaps
10
2023
56
5.980
Why?
Head and Neck Neoplasms
9
2023
336
4.520
Why?
Neck Dissection
6
2021
43
1.940
Why?
Neck
4
2021
116
1.600
Why?
Retrospective Studies
22
2023
6462
1.270
Why?
Length of Stay
3
2019
683
1.040
Why?
Postoperative Complications
6
2022
1035
1.030
Why?
Mandibular Reconstruction
1
2023
10
0.920
Why?
Middle Aged
25
2023
13076
0.880
Why?
Thyroidectomy
3
2021
103
0.860
Why?
Head
2
2021
78
0.860
Why?
Critical Pathways
2
2019
36
0.830
Why?
Intraoperative Care
1
2021
58
0.810
Why?
Intraoperative Complications
2
2021
125
0.810
Why?
Chylothorax
1
2021
16
0.780
Why?
Hypotension
1
2021
67
0.770
Why?
Carcinoma, Squamous Cell
2
2022
385
0.770
Why?
Vasoconstrictor Agents
1
2021
88
0.770
Why?
Aged, 80 and over
13
2022
3430
0.750
Why?
Morbidity
1
2021
149
0.750
Why?
Venous Thrombosis
1
2021
102
0.750
Why?
Paranasal Sinus Neoplasms
2
2010
27
0.730
Why?
Naproxen
1
2019
8
0.730
Why?
Orthognathic Surgical Procedures
1
2019
2
0.720
Why?
Mandible
1
2019
24
0.710
Why?
Reoperation
1
2021
453
0.700
Why?
Thyroid Neoplasms
2
2012
162
0.680
Why?
Edema
1
2019
74
0.680
Why?
Health Status Indicators
1
2019
94
0.670
Why?
Male
26
2023
27335
0.660
Why?
Female
28
2023
28457
0.650
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2019
142
0.650
Why?
Health Resources
1
2019
80
0.640
Why?
Humans
41
2023
54304
0.640
Why?
Aged
19
2021
10054
0.630
Why?
Academic Medical Centers
2
2019
146
0.610
Why?
Thigh
2
2015
40
0.580
Why?
Laryngectomy
2
2014
28
0.580
Why?
Adult
18
2021
14189
0.570
Why?
Melanoma
2
2010
313
0.570
Why?
Treatment Outcome
15
2021
5609
0.560
Why?
Surgical Flaps
2
2023
135
0.550
Why?
Patient Discharge
2
2019
352
0.540
Why?
Databases, Factual
2
2019
683
0.520
Why?
Carcinoma, Papillary
2
2012
65
0.470
Why?
Video-Assisted Surgery
1
2013
3
0.460
Why?
Parathyroidectomy
2
2012
75
0.460
Why?
Tissue and Organ Harvesting
1
2013
27
0.460
Why?
Soft Tissue Injuries
1
2013
22
0.450
Why?
Neck Injuries
1
2013
26
0.450
Why?
Endoscopy
1
2013
131
0.430
Why?
Speech, Esophageal
1
2010
1
0.390
Why?
Palatal Obturators
1
2010
2
0.380
Why?
Maxilla
1
2010
29
0.380
Why?
Carcinoma, Merkel Cell
3
2016
47
0.370
Why?
Parathyroid Neoplasms
1
2010
44
0.370
Why?
Nose Neoplasms
1
2010
10
0.370
Why?
Nasal Mucosa
1
2010
22
0.370
Why?
Preoperative Care
1
2011
184
0.350
Why?
Adolescent
9
2019
6896
0.340
Why?
Adenoma
1
2010
142
0.340
Why?
Follow-Up Studies
6
2023
2389
0.330
Why?
Graft Survival
2
2019
165
0.320
Why?
Young Adult
7
2019
4313
0.320
Why?
Neoplasm Recurrence, Local
3
2022
645
0.300
Why?
Colitis, Ulcerative
2
2018
52
0.300
Why?
Radiotherapy, Adjuvant
3
2019
66
0.300
Why?
Crohn Disease
2
2018
97
0.290
Why?
Pain, Postoperative
3
2022
160
0.260
Why?
Skin Neoplasms
3
2016
532
0.250
Why?
TOR Serine-Threonine Kinases
2
2016
85
0.250
Why?
Comorbidity
2
2019
666
0.250
Why?
Adenocarcinoma
2
2023
428
0.240
Why?
Prognosis
3
2019
2126
0.240
Why?
Adenoma, Pleomorphic
1
2023
7
0.240
Why?
Carcinoma, Ductal
1
2023
8
0.240
Why?
Paranasal Sinuses
1
2023
25
0.230
Why?
Salivary Gland Neoplasms
1
2023
24
0.230
Why?
Scapula
1
2023
19
0.230
Why?
Forearm
1
2023
41
0.230
Why?
Ambulatory Care Facilities
1
2023
138
0.220
Why?
Sinusitis
1
2023
60
0.220
Why?
Tramadol
1
2022
28
0.220
Why?
Ambulatory Care
1
2023
231
0.210
Why?
Microsurgery
1
2021
35
0.210
Why?
Anastomosis, Surgical
1
2021
72
0.200
Why?
Recurrent Laryngeal Nerve Injuries
1
2021
11
0.200
Why?
Salvage Therapy
1
2022
145
0.200
Why?
Gastrointestinal Agents
2
2018
37
0.200
Why?
Infusions, Intravenous
1
2021
231
0.200
Why?
Indocyanine Green
2
2011
39
0.190
Why?
Drug Administration Schedule
1
2021
401
0.190
Why?
Robotics
1
2021
45
0.190
Why?
Laser Therapy
2
2011
91
0.190
Why?
Cohort Studies
2
2019
1547
0.190
Why?
Odds Ratio
1
2021
600
0.180
Why?
Reproducibility of Results
4
2023
1294
0.180
Why?
Analgesics, Opioid
2
2022
500
0.180
Why?
Acetaminophen
1
2022
350
0.170
Why?
Ultrasonography
2
2012
486
0.170
Why?
Neoplasm Staging
3
2010
805
0.170
Why?
Combined Modality Therapy
2
2012
693
0.170
Why?
Drug Monitoring
1
2018
85
0.160
Why?
Hospital Costs
1
2019
84
0.160
Why?
Postoperative Care
1
2019
121
0.160
Why?
Graft Rejection
1
2019
161
0.160
Why?
Analysis of Variance
1
2019
634
0.150
Why?
Heart Defects, Congenital
1
2023
608
0.150
Why?
Patient Readmission
1
2019
242
0.140
Why?
Antibodies, Monoclonal, Humanized
1
2018
240
0.140
Why?
Benzoxazoles
1
2016
12
0.140
Why?
Prospective Studies
4
2022
2604
0.140
Why?
Proto-Oncogene Proteins c-myb
1
2015
9
0.130
Why?
United States
2
2019
5204
0.130
Why?
Cell Proliferation
2
2016
1097
0.120
Why?
Pyrimidines
1
2016
196
0.120
Why?
Regression Analysis
2
2012
444
0.120
Why?
Nuclear Proteins
1
2015
253
0.110
Why?
Child
4
2018
7372
0.110
Why?
Skin Transplantation
1
2013
50
0.110
Why?
Arkansas
1
2019
2097
0.110
Why?
Apoptosis
2
2016
1302
0.110
Why?
Osteocalcin
1
2012
46
0.110
Why?
Quality of Life
1
2019
922
0.110
Why?
Survival
1
2012
16
0.110
Why?
Equipment Design
1
2013
318
0.100
Why?
Leukoplakia, Oral
1
2011
8
0.100
Why?
Aminolevulinic Acid
1
2011
10
0.100
Why?
Iodine Radioisotopes
1
2012
43
0.100
Why?
Lasers, Dye
1
2011
10
0.100
Why?
Recurrence
2
2012
692
0.100
Why?
Decision Support Techniques
1
2012
72
0.100
Why?
Hyperparathyroidism, Primary
1
2012
50
0.100
Why?
Photosensitizing Agents
1
2011
24
0.100
Why?
Epigenesis, Genetic
1
2015
399
0.100
Why?
Infrared Rays
1
2011
27
0.100
Why?
Dose-Response Relationship, Radiation
1
2012
204
0.100
Why?
Photochemotherapy
1
2011
37
0.100
Why?
Hospital Mortality
1
2014
466
0.100
Why?
Biopsy, Fine-Needle
1
2012
116
0.100
Why?
Thyroid Gland
2
2022
96
0.100
Why?
Transcription Factors
1
2015
622
0.100
Why?
Fascia
1
2010
6
0.100
Why?
Lymph Node Excision
1
2012
140
0.100
Why?
Laser Coagulation
1
2011
27
0.100
Why?
Coloring Agents
1
2011
84
0.100
Why?
Tongue Neoplasms
1
2010
14
0.090
Why?
Speech Intelligibility
1
2010
15
0.090
Why?
Veins
1
2011
74
0.090
Why?
Parathyroid Hormone
1
2012
196
0.090
Why?
Carcinoma
1
2012
154
0.090
Why?
Kaplan-Meier Estimate
1
2012
514
0.090
Why?
Mammary Neoplasms, Experimental
1
2011
135
0.090
Why?
Deglutition
1
2010
37
0.090
Why?
Vascular Diseases
1
2011
77
0.090
Why?
Survival Analysis
1
2012
736
0.090
Why?
Disease-Free Survival
1
2011
488
0.090
Why?
Tracheostomy
1
2010
81
0.090
Why?
Lymph Nodes
1
2012
284
0.090
Why?
Quality Indicators, Health Care
1
2010
98
0.090
Why?
Risk Assessment
1
2014
1361
0.080
Why?
Guideline Adherence
1
2010
148
0.080
Why?
Predictive Value of Tests
1
2012
1044
0.080
Why?
Survival Rate
1
2010
954
0.080
Why?
Positron-Emission Tomography
1
2010
323
0.080
Why?
Pneumothorax, Artificial
1
2007
1
0.080
Why?
Urologic Surgical Procedures
1
2007
28
0.080
Why?
Diaphragm
1
2007
29
0.070
Why?
Models, Biological
1
2011
825
0.070
Why?
Disease Progression
1
2010
915
0.070
Why?
Severity of Illness Index
3
2018
1083
0.070
Why?
Atrioventricular Node
1
2006
5
0.070
Why?
Tachycardia, Ectopic Atrial
1
2006
3
0.070
Why?
Cryosurgery
1
2006
38
0.070
Why?
Azepines
2
2016
22
0.070
Why?
Pulmonary Veins
1
2005
31
0.070
Why?
Pilot Projects
2
2022
805
0.070
Why?
Risk Factors
1
2014
3934
0.060
Why?
Xenograft Model Antitumor Assays
2
2016
219
0.060
Why?
Laparoscopy
1
2007
186
0.060
Why?
Triazoles
2
2016
119
0.060
Why?
Salivary Ducts
1
2023
5
0.060
Why?
Parotid Gland
1
2023
16
0.060
Why?
Facial Bones
1
2023
22
0.060
Why?
Ubiquitin Thiolesterase
1
2023
23
0.060
Why?
Ibuprofen
1
2022
28
0.060
Why?
Atrial Fibrillation
1
2005
197
0.050
Why?
Tumor Suppressor Proteins
1
2023
141
0.050
Why?
Recurrent Laryngeal Nerve
1
2021
20
0.050
Why?
Laryngeal Nerves
1
2021
19
0.050
Why?
Glossectomy
1
2021
6
0.050
Why?
Tongue
1
2021
41
0.050
Why?
Arteries
1
2021
101
0.050
Why?
Immunohistochemistry
1
2023
1090
0.050
Why?
Cell Line, Tumor
2
2015
1551
0.040
Why?
Pain Management
1
2021
155
0.040
Why?
Mice
3
2016
6428
0.040
Why?
Statistics, Nonparametric
1
2018
230
0.040
Why?
Colonoscopy
1
2018
105
0.040
Why?
Reference Values
1
2018
353
0.040
Why?
Enzyme-Linked Immunosorbent Assay
1
2018
314
0.040
Why?
Tomography, X-Ray Computed
1
2023
1222
0.040
Why?
Chile
1
2016
4
0.040
Why?
Immunotherapy
1
2018
264
0.040
Why?
Enterocolitis, Pseudomembranous
1
2016
25
0.040
Why?
Age of Onset
1
2016
117
0.030
Why?
Digestive System Surgical Procedures
1
2016
36
0.030
Why?
Age Distribution
1
2016
198
0.030
Why?
Mice, Inbred NOD
1
2016
99
0.030
Why?
Immunoenzyme Techniques
1
2016
166
0.030
Why?
Mice, SCID
1
2016
196
0.030
Why?
Drug Synergism
1
2016
171
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
18
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
206
0.030
Why?
Acetylation
1
2015
99
0.030
Why?
Tumor Cells, Cultured
1
2016
477
0.030
Why?
Enhancer Elements, Genetic
1
2015
64
0.030
Why?
Drug Therapy, Combination
1
2016
426
0.030
Why?
Neoplasm Metastasis
1
2015
252
0.030
Why?
Immunosuppressive Agents
1
2016
248
0.030
Why?
Blotting, Western
1
2016
684
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2016
674
0.030
Why?
Chromatin
1
2015
156
0.030
Why?
Animals
3
2016
14402
0.030
Why?
Amino Acid Chloromethyl Ketones
1
2013
17
0.030
Why?
Referral and Consultation
1
2016
307
0.030
Why?
Tissue Fixation
1
2013
35
0.030
Why?
Phagosomes
1
2013
21
0.030
Why?
Paraffin Embedding
1
2013
56
0.030
Why?
Formaldehyde
1
2013
49
0.030
Why?
Cell Cycle Proteins
1
2015
198
0.030
Why?
Registries
1
2016
552
0.030
Why?
Caspases
1
2013
146
0.030
Why?
Enzyme Activation
1
2013
328
0.030
Why?
Protein Binding
1
2015
736
0.030
Why?
Promoter Regions, Genetic
1
2015
520
0.030
Why?
Preoperative Period
1
2012
59
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2018
1060
0.030
Why?
RNA, Messenger
1
2016
1203
0.030
Why?
Protein Kinase Inhibitors
1
2013
216
0.030
Why?
Administration, Topical
1
2011
71
0.030
Why?
Hospitalization
1
2016
702
0.030
Why?
Up-Regulation
1
2013
509
0.030
Why?
Postoperative Period
1
2012
189
0.030
Why?
Cell Survival
1
2013
657
0.030
Why?
Injections, Intravenous
1
2011
148
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2015
868
0.020
Why?
Cancer Care Facilities
1
2010
21
0.020
Why?
Multivariate Analysis
1
2012
643
0.020
Why?
Leg
1
2011
130
0.020
Why?
Lasers
1
2011
143
0.020
Why?
Quality Assurance, Health Care
1
2010
164
0.020
Why?
Time Factors
1
2016
3207
0.020
Why?
Biopsy
1
2011
693
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1476
0.020
Why?
Child, Preschool
1
2016
4161
0.020
Why?
Carbon Dioxide
1
2007
103
0.020
Why?
Atrial Function
1
2005
7
0.020
Why?
Secondary Prevention
1
2006
89
0.020
Why?
Electrocardiography, Ambulatory
1
2005
25
0.020
Why?
Angiography
1
2005
148
0.020
Why?
Heart Rate
1
2006
358
0.020
Why?
Electrocardiography
1
2006
290
0.020
Why?
Catheter Ablation
1
2005
131
0.010
Why?
Logistic Models
1
2005
991
0.010
Why?
Moreno's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description